Hepatocellular Carcinoma Registry for Turkey (3K Trial)

Bayer

Status: Completed

Conditions: Hepatocellular Carcinoma

Treatments: Other: No Intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT01473121

NX1110TR (Other Identifier)

15807

Details and patient eligibility

About

This registry study is national, multi-center, prospective study without any interventions to the treatment strategies and/or decisions of the investigators. It is designed in order to determine the general profile of HCC patients in Turkey. Socio-demographic characteristics, family history, medical history and treatment pattern of HCC patients will be evaluated.

Enrollment: 600 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• To be diagnosed with hepatocellular carcinoma in last 3 months
• To be older than 18 years old
• To sign informed consent form (ICF)

Exclusion criteria

• Patients that does not sign or withdraw informed consent form.
• According to investigator's opinion; existence of any situation/condition that will significantly complicate patient follow up.
• Currently or previously taking part in 3K observational study

Trial design

600 participants in 1 patient group

Group 1

Treatment:

Other: No Intervention